{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Hologic, Inc."},"Symbol":{"label":"Symbol","value":"HOLX"},"Address":{"label":"Address","value":"250 CAMPUS DRIVE, MARLBOROUGH, Massachusetts, 01752, United States"},"Phone":{"label":"Phone","value":"+1 508 263-2900"},"Industry":{"label":"Industry","value":"Medical Electronics"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts."},"CompanyUrl":{"label":"Company Url","value":"http://www.hologic.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Essex D. Mitchell","title":"Chief Operating Officer"},{"name":"Paul Malenchini","title":"Chief Information Officer"},{"name":"Stephen P. MacMillan","title":"Chairman, President & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}